We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
CAS:56-92-8
Fórmula Molecular:C5H11Cl2N3
Peso Molecular:184.07
EINECS:200-298-4
Sinónimos:2-[4-IMIDAZOYL]-ETILAMINA DICLORHIDRATO; 2-(1H-IMIDAZOL-4-YL)-ETILAMINA 2HCL; 2-(1H-IMIDAZOL-4-YL)ETILAMINA DICLORHIDRATO; 1H-IMIDAZOL-4-ETHANAMINE; DICLORHIDRATO; 2-imidazol-4-ylethylamine diclorhidrato; la HISTAMINA DICHLORHYDRATE; DIHIDROCLORURO de HISTAMINA, PH EUR; DIHIDROCLORURO de HISTAMINA (1H-IMIDAZOL - 4-ETHAN
Dihidrocloruro de histamina aparece como incoloro cristales prismáticos o polvo blanco cristalino, sin olor. Tiene un sabor agrio y salado. Sensible a la luz y el aire. Ha higroscopicidad.
| Elemento | Especificación |
| La pureza | 99% |
| MW | 184.07 |
| Punto de fusión | 249-252 °C(lit.) |
| EINECS | 200-298-4 |
| Condiciones de almacenamiento | 2-8°C |
Dihidrocloruro de histamina se utiliza para una remisión sostenida y la prevención de la recurrencia en pacientes adultos con leucemia mieloide aguda (LMA) después de la primera remisión de tratamiento. Este medicamento puede reducir los radicales de oxígeno producido por la autofagia en las células, inhiben la nicotinamida adenina dinucleótido fosfato oxidasa, y evitar la interleucina-2 a partir de la activación de las células NK y células T.
Por lo general lleno en 25kg/drum,y también se pueden hacer paquetes personalizados.
ES 
EN 
ZH 
DE 
KO 
PT 
FR 
TH 
AR 
IT 
VI 
NL 
RU 
